Watson Pharmaceuticals is a leading specialty pharmaceutical company that uses science and market insight to develop responsive products for a changing world. Since its establishment in 1984, the company has pursued a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses. Additionally, Watson is uniquely positioned with its infrastructure and internal research and development capabilities to support a leading generic business and a growing brand business. It develops, manufactures and markets an array of brand and generic pharmaceutical products. Some of the company s flagship products include Ferrlecit, Oxytrol, Androderm, Trelstar and Reprexain. Watson Pharmaceuticals is headquartered in Corona, Calif.